Erythropoietin enhances immune responses in mice
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Erythropoietin (Epo) is the main erythropoietic hormone. Recombinant human Epo (rHuEpo) is thus used in clinical practice for the treatment of anemia. Accumulating data reveals that Epo exerts pleiotropic activities. We have previously shown an anti‐neoplastic activity of Epo in murine multiple myeloma (MM) models, and in MM patients. Our findings that this anti‐neoplastic effect operates via CD8+ T lymphocytes led us to hypothesize that Epo possesses a wider range of immunomodulatory functions. Here we demonstrate the effect of Epo on B lymphocyte responses, focusing on three experimental models: (i) tumor‐bearing mice, (5T2 MM mouse); (ii) antigen‐injected healthy mice; and (iii) antigen‐injected transgenic mice (tg6), overexpressing human Epo. In the MM model, despite bone marrow dysfunction, Epo‐treated mice retained higher levels of endogenous polyclonal immunoglobulins, compared to their untreated controls. In both Epo‐treated wild type and tg6 mice, Epo effect was manifested in the higher levels of splenocyte proliferative response induced in vitro by lipopolysaccharide. Furthermore, these mice had increased in vivo production of anti‐dinitrophenyl (DNP) antibodies following immunization with DNP‐keyhole limpet hemocyanin. Epo‐treated mice showed an enhanced immune response also to the clinically relevant hepatitis B surface antigen. These findings suggest a potential novel use of rHuEpo as an immunomodulator. See accompanying commentary: http://dx.doi.org/10.1002/eji.200737401
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
Cited by
The pleiotropic effects of erythropoietin in infection and inflammation
Nairz, M., Sonnweber, T., Schroll, A., Theurl, I., & Weiss, G. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.005 · Cited by 161
“This EPO-mediated expansion of B cells is associated with an improved antibody response to vaccines [38].”
BackgroundIron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
Jackson, A., Nanton, M. R., O’Donnell, H., Akue, A. D., & McSorley, S. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001198 · Cited by 85
Activities of erythropoietin on tumors: An immunological perspective
Ghezzi, P., & Mengozzi, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737401 · Cited by 9
Metadata
- Authors
- Katz, O., Gil, L., Lifshitz, L., Prutchi‐Sagiv, S., Gassmann, M., Mittelman, M., & Neumann, D.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2007-05-24
- Volume
- 37
- Issue
- 6
- Pages
- 1584-1593
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2115062753
- Cited by
- 58
- References
- 2
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.